-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Allovir, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2024.
- Allovir, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$32.3 M, a 25.3% increase year-over-year.
- Allovir, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$189 M, a 10.4% decline year-over-year.
- Allovir, Inc. annual Operating Income (Loss) for 2023 was -$200 M, a 16.8% decline from 2022.
- Allovir, Inc. annual Operating Income (Loss) for 2022 was -$171 M, a 0.82% decline from 2021.
- Allovir, Inc. annual Operating Income (Loss) for 2021 was -$170 M, a 138% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)